{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T10:24:13Z","timestamp":1787826253310,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The study aimed to examine the association of pulmonary hypertension (PH) and the use of inhaled nitric oxide (iNO) with retinopathy of prematurity (ROP) in very low birth weight (VLBW) infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Utilizing the United States National Inpatient Sample (NIS) database, VLBW infants were identified. Chi-square and Fisher\u2019s exact tests were used to calculate unadjusted odds ratios (ORs) for the presence of ROP in relation to PH and iNO therapy. Adjusted odds ratios (aORs) were calculated using logistic regression while controlling for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,007,141 infants, 30,401 (3%) had PH. ROP was diagnosed more frequently with PH (22.3% vs 13.6%; aOR: 1.32, 95% CI: 1.28\u20131.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Severe ROP was less frequent in iNO-treated PH infants (4.33% vs 5.35%; aOR: 0.82, 95% CI: 0.70\u20130.96,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02). In extremely low birth weight (ELBW) infants with PH, iNO use was associated with lower rates of severe ROP (aOR: 0.68, 95% CI: 0.57\u20130.81,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PH is associated with an increased risk of ROP. iNO therapy is associated with a decreased prevalence of severe ROP in PH-affected infants. Further studies are needed to assess the early use of vascular modulators in mitigating the risk for ROP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Premature infants diagnosed with pulmonary hypertension are at increased risk for ROP. Severe ROP is less encountered when inhaled nitric oxide was used in this vulnerable population.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>This is the first study to assess the interaction between pulmonary hypertension, its treatment, and the development of ROP in premature infants.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The study suggests the need for future studies to assess the efficacy of early use of vascular modulators in mitigating the risk of ROP.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41390-025-04323-3","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T16:47:28Z","timestamp":1754758048000},"page":"915-920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pulmonary hypertension, inhaled nitric oxide, and retinopathy of prematurity: evidence from the U.S. national database"],"prefix":"10.1038","volume":"99","author":[{"given":"Seohyun","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen A. A.","family":"Farghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Ramey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alshimaa","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"4323_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.survophthal.2022.11.007","volume":"68","author":"M Fevereiro-Martins","year":"2023","unstructured":"Fevereiro-Martins, M., Marques-Neves, C., Guimar\u00e3es, H. & Bicho, M. Retinopathy of prematurity: a review of pathophysiology and signaling pathways. Surv. Ophthalmol. 68, 175\u2013210 (2023).","journal-title":"Surv. Ophthalmol."},{"key":"4323_CR2","doi-asserted-by":"publisher","first-page":"102967","DOI":"10.1016\/j.arcmed.2024.102967","volume":"55","author":"H Garc\u00eda","year":"2024","unstructured":"Garc\u00eda, H. et al. Global prevalence and severity of retinopathy of prematurity over the last four decades (1985\u20132021): a systematic review and meta-analysis. Arch. Med. Res. 55, 102967 (2024).","journal-title":"Arch. Med. Res."},{"key":"4323_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.oret.2022.10.010","volume":"7","author":"L Thangamathesvaran","year":"2023","unstructured":"Thangamathesvaran, L., Wang, J., Repka, M. X. & Scott, A. W. Trends in retinopathy of prematurity care in the United States 2009-2018: a nationwide analysis using National Inpatient Sample. Ophthalmol. Retin. 7, 360\u2013366 (2023).","journal-title":"Ophthalmol. Retin."},{"key":"4323_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100417","volume":"4","author":"WC Lin","year":"2023","unstructured":"Lin, W. C. et al. Oxygenation fluctuations associated with severe retinopathy of prematurity: Insights from a multimodal deep learning approach. Ophthalmol. Sci. 4, 100417 (2023).","journal-title":"Ophthalmol. Sci."},{"key":"4323_CR5","doi-asserted-by":"publisher","first-page":"151202","DOI":"10.1016\/j.sempedsurg.2022.151202","volume":"31","author":"B Mahmood","year":"2022","unstructured":"Mahmood, B. Persistent pulmonary hypertension of newborn. Semin. Pediatr. Surg. 31, 151202 (2022).","journal-title":"Semin. Pediatr. Surg."},{"key":"4323_CR6","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1542\/peds.2006-3037","volume":"120","author":"S Herna\u0301ndez-Di\u0301az","year":"2007","unstructured":"Herna\u0301ndez-Di\u0301az, S., Van Marter, L. J., Werler, M. M., Louik, C. & Mitchell, A. A. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 120, e272\u2013e282 (2007).","journal-title":"Pediatrics"},{"key":"4323_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","volume":"63","author":"SJ Kim","year":"2018","unstructured":"Kim, S. J. et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv. Ophthalmol. 63, 618\u2013637 (2018).","journal-title":"Surv. Ophthalmol."},{"key":"4323_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1203\/01.PDR.0000156507.03879.19","volume":"57","author":"I Hamon","year":"2005","unstructured":"Hamon, I. et al. Early inhaled nitric oxide improves oxidative balance in very preterm infants. Pediatr. Res. 57, 637\u2013643 (2005).","journal-title":"Pediatr. Res."},{"key":"4323_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-02810-x","volume":"23","author":"A Chor\u0119ziak-Michalak","year":"2023","unstructured":"Chor\u0119ziak-Michalak, A. et al. Potential role of eNOS and EDN-1 gene polymorphisms in the development and progression of retinopathy of prematurity. Bmc. Ophthalmol. 23, 78 (2023).","journal-title":"Bmc. Ophthalmol."},{"key":"4323_CR10","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64944","volume":"10","author":"T Ninchoji","year":"2021","unstructured":"Ninchoji, T. et al. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin. Elife 10, e64944 (2021).","journal-title":"Elife"},{"key":"4323_CR11","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.ajpath.2015.02.021","volume":"185","author":"KS Edgar","year":"2015","unstructured":"Edgar, K. S., Matesanz, N., Gardiner, T. A., Katusic, Z. S. & McDonald, D. M. Hyperoxia depletes (6R)-5,6,7,8-tetrahydrobiopterin levels in the neonatal retina. Am. J. Pathol. 185, 1769\u20131782 (2015).","journal-title":"Am. J. Pathol."},{"key":"4323_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/antiox13020148","volume":"13","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Buonfiglio, F., Fie\u00df, A., Pfeiffer, N. & Gericke, A. Retinopathy of prematurity\u2014targeting hypoxic and redox signaling pathways. Antioxidants 13, 148 (2024).","journal-title":"Antioxidants"},{"key":"4323_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.pcl.2009.04.004","volume":"56","author":"GG Konduri","year":"2009","unstructured":"Konduri, G. G. & Kim, U. O. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr. Clin. North Am. 56, 579\u2013600 (2009).","journal-title":"Pediatr. Clin. North Am."},{"key":"4323_CR14","first-page":"696","volume":"70","author":"EA Reece","year":"1987","unstructured":"Reece, E. A. et al. Persistent pulmonary hypertension: assessment of perinatal risk factors. Obstet. Gynecol. 70, 696\u2013700 (1987).","journal-title":"Obstet. Gynecol."},{"key":"4323_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jcrc.2018.12.008","volume":"50","author":"S Vallabhajosyula","year":"2019","unstructured":"Vallabhajosyula, S. et al. Doppler-defined pulmonary hypertension in sepsis and septic shock. J. Crit. Care. 50, 201\u2013206 (2019).","journal-title":"J. Crit. Care."},{"key":"4323_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0943-1","volume":"14","author":"JC Rivera","year":"2017","unstructured":"Rivera, J. C. et al. Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies. J. Neuroinflammation 14, 165 (2017).","journal-title":"J. Neuroinflammation"},{"key":"4323_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.siny.2011.08.007","volume":"17","author":"J Lee","year":"2012","unstructured":"Lee, J. & Dammann, O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin. Fetal Neonatal Med. 17, 26\u201329 (2012).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"4323_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/09286586.2022.2036766","volume":"30","author":"F Bhatti","year":"2023","unstructured":"Bhatti, F. et al. Association of cardiovascular disease with retinopathy of prematurity. Ophthalmic Epidemiol. 30, 95\u2013102 (2023).","journal-title":"Ophthalmic Epidemiol."},{"key":"4323_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2045894018760166","volume":"8","author":"SK Yum","year":"2018","unstructured":"Yum, S. K. et al. Impact of histologic chorioamnionitis on pulmonary hypertension and respiratory outcomes in preterm infants. Pulm. Circ. 8, 1\u20137 (2018).","journal-title":"Pulm. Circ."},{"key":"4323_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1152\/japplphysiol.01336.2009","volume":"108","author":"GR Polglase","year":"2010","unstructured":"Polglase, G. R. et al. Intrauterine inflammation causes pulmonary hypertension and cardiovascular sequelae in preterm lambs. J. Appl. Physiol. 108, 1757\u20131765 (2010).","journal-title":"J. Appl. Physiol."},{"key":"4323_CR21","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.freeradbiomed.2004.09.008","volume":"37","author":"MH Beauchamp","year":"2004","unstructured":"Beauchamp, M. H. et al. Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. Free Radic. Biol. Med. 37, 1885\u20131894 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"4323_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.jp.7200511","volume":"21","author":"JA Englert","year":"2001","unstructured":"Englert, J. A. et al. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants. J. Perinatol. 21, 21\u201326 (2001).","journal-title":"J. Perinatol."},{"key":"4323_CR23","doi-asserted-by":"publisher","first-page":"F188","DOI":"10.1136\/fn.84.3.F188","volume":"84","author":"K Hirano","year":"2001","unstructured":"Hirano, K. et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 84, F188\u2013F193 (2001).","journal-title":"Arch. Dis. Child Fetal Neonatal Ed."},{"key":"4323_CR24","first-page":"507","volume":"16","author":"MK Sabzehei","year":"2013","unstructured":"Sabzehei, M. K. et al. Retinopathy of prematurity: incidence, risk factors, and outcome. Arch. Iran. Med. 16, 507\u2013512 (2013).","journal-title":"Arch. Iran. Med."},{"key":"4323_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","volume":"157","author":"JM Di Fiore","year":"2010","unstructured":"Di Fiore, J. M. et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J. Pediatr. 157, 69\u201373 (2010).","journal-title":"J. Pediatr."},{"key":"4323_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13052-021-01011-w","volume":"47","author":"C Dani","year":"2021","unstructured":"Dani, C. et al. Incidence and risk factors of retinopathy of prematurity in an Italian cohort of preterm infants. Ital. J. Pediatr. 47, 64 (2021).","journal-title":"Ital. J. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04323-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04323-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:21:16Z","timestamp":1774527676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-04323-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4323"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-04323-3","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}